Innovations In Medicine

ReachMD

Stay current with the science shaping the future of healthcare with Innovations in Medicine. Here, leading clinicians, researchers, and scientific experts come together to examine emerging evidence and to share their expert perspectives across therapeutic areas so that you can gain a deeper understanding of today's clinical landscape and tomorrow's standards of care.

Episodes

  1. Apr 30

    Integrating Patient Perspectives in Dermatologic Care

    Guest: Mona Shahriari MD, FAAD Guest: Linda Stein Gold, MD Guest: Jennifer Soung, MD Clinicians are trying to align care with individual patient needs for the approximately eight million American adults and over 125 million people worldwide living with psoriasis.1 In the ENCOMPASS study’s US arm, researchers examined treatment experiences, satisfaction, and perceptions of therapies through quantitative surveys and qualitative interviews.2 Dr. Mona Shahriari sits down with Dr. Linda Stein Gold and Dr. Jennifer Soung to share their key findings from this dataset and their implications for providing patient-centered care in psoriasis. Dr. Shahriari is an Associate Clinical Professor of Dermatology at Yale University School of Medicine in New Haven, Connecticut, and she serves as the Associate Director of Clinical Trials and co-founder of Central Connecticut Dermatology. Dr. Stein Gold is the Director of Dermatology Clinical Research for the Henry Ford Health System in Detroit as well as the Division Head of Dermatology at Henry Ford in West Bloomfield, Michigan. Dr. Soung is the Founder and Director of Clinical Research at Southern California Dermatology in Santa Ana, and she serves on the clinical faculty at the University of California Los Angeles Harbor Medical Center. References: National Psoriasis Foundation. Psoriasis Statistics. Available at: https://www.psoriasis.org/content/statistics. Accessed February 2026. Stein Gold L, Soung …

  2. Feb 13

    Gene Therapy, the Future of Eye Care?

    Guest: Courtney Crawford, MD, FACS Guest: Raj Maturi, MD While anti-VEGF therapy can deliver vision gains with consistent, frequent injections in clinical trials, it may be challenging to sustain this in real-world practice.1 Ocular gene therapy could be a potential option for patients with neovascular age-related macular degeneration if approved. With this approach, transgenes are delivered to the eye by adeno-associated viruses (AAVs).2-4 Learn more with Drs. Courtney Crawford and Raj Maturi, who shared their perspectives on investigational gene therapy, patient conversations, and surgical considerations at the 2025 American Academy of Ophthalmology annual meeting in Orlando, Florida. Dr. Crawford is a board-certified retina specialist and founder of Star Retina in Burleson, Texas. He previously served for 10 years as a physician in the U.S. Army, where he attained the rank of Lieutenant Colonel. Dr. Maturi is a board-certified retina specialist at the Midwest Eye Institute and founder of Retina Partners Midwest in Carmel, Indiana, where he focuses on macular, retina, and vitreous care. References: Weng CY, Singh RP, Gillies MC, Regillo CD. Optimizing visual outcomes in patients with neovascular age-related macular degeneration: the potential value of sustained anti-VEGF therapy. Ophthalmic Surg Lasers Imaging Retina. 2023;54:654–659. Petrich J, Marchese D, Jenkins C, Storey M, Blind J. …

  3. Feb 12

    Tau and Neurodegeneration in Alzheimer’s Disease: Bridging Pathology and Clinical Progression Through Biomarkers

    Host: Yuval Zabar, MD Guest: Michelle Mielke, PhD Guest: Henrik Zetterberg, MD, PhD For the latest insights on tau and neurodegeneration biomarkers in Alzheimer’s disease (AD), tune in to this recorded presentation featuring Doctor Michelle Mielke and Professor Henrik Zetterberg. Together, they delve into the role of tau in AD, exploring the ‘tau cascade’, the current use of tau and neurodegeneration biomarkers in tracking disease progression, and how the AD biomarker landscape may evolve over time. Doctor Mielke is a Professor of Epidemiology and Neurology at the Wake Forest University School of Medicine, and Professor Zetterberg is a Professor of Neurochemistry at the University of Gothenburg. To learn more about tau in Alzheimer’s disease, explore the Know Tau medical education platform. Know Tau is created and funded by Biogen and is intended for healthcare professionals only.

  4. 09/28/2020

    Sci-Fi in the OR: Utilizing Holograms in Cardiac Ablation Procedures

    Host: Matthew Sorrentino, MD Guest: Jennifer N. Avari Silva, MD Each year, more than 75 thousand cardiac ablation procedures are performed in the United States alone. Could something straight out of a science-fiction movie like holograms help improve physician accuracy and reduce the complications typically associated with this procedure? Talk a walk on the futuristic side of medicine with Dr. Matthew Sorrentino and Dr. Jennifer Silva, who co-led a team that tested a unique headset using mixed reality technology during cardiac ablation procedures at St. Louis Children’s Hospital.

  5. 08/01/2016

    How Information Technology Will Revolutionize Mental Health Care

    Host: Matt Birnholz, MD Psychiatry gets a bad rep for being one of the more "technophobic" fields in clinical medicine. This negative association stems in part to the difficulty in tracking changes in mood, cognition, and certain behaviors over time. But there is a growing contingency of psychiatric clinicians who are bringing technology into this specialty to help propel standards in mental health care. Dr. Adam Kaplin, Assistant Professor of Psychiatry at Johns Hopkins School of Medicine and Principle Psyciatric Consultant to the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers of Excellence, joins Dr. Jennifer Caudle to discuss ways in which technological innovations can enhance psychiatric care and decrease stigma surrounding mental illness.

  • 5 Episodes

About

Stay current with the science shaping the future of healthcare with Innovations in Medicine. Here, leading clinicians, researchers, and scientific experts come together to examine emerging evidence and to share their expert perspectives across therapeutic areas so that you can gain a deeper understanding of today's clinical landscape and tomorrow's standards of care.

Information

  • Creator
    ReachMD
  • Years Active
    2022 - 2026
  • Episodes
    5
  • Rating
    Clean
  • Copyright
    © Copyright 2026 ReachMD. All rights reserved.
  • Show Website
    Innovations In Medicine